Cheap Cialis Blogger | Search results for "proof"

PLoS Medicine August 28 \"...a two-serving-per-day increment bounded by whole grain consumption was interchangeable with a 21% reduction halfway risk of classification 2 diabetes.\" \"Proof: Whole grain intake is inversely alike with risk of facsimile 2 diabetes, besides this club is stronger through bran than since germ. Findings from prospective cohort studies as usual aid enlarging whole grain consumption owing to the prevention of head 2 diabetes.\" Cheap Generic Viagra

Tags: diabetes, grain, risk, cohort, consumption

For expert analysis of legal ramifications of the Codex, check out "Decoding the Codex ", written by lawyer Alan Dumoff in the December 2004 issue of "Alternative and Complementary Therapies". You may need to find a library that subscribes to the journal to get look at the print version. Alternatively an online subscription can be had at Mary Ann Liebert Inc. Publishers.. Although focused on legal ramifications pertaining to US law, the issues can be universally applied. In concluding his analysis, Mr Dumoff acknowleges there is a large mistrust of regulatory regimes that become overzealous on two fronts, in their pursuit to not allow harmful products into the market place, an error of commission, and in creating standards of proof that deny access to products, error of omission. In the context of Codex both can be detrimental to public health, a conundrum indeed. Cheap Generic Viagra

Tags: codex, products, dumoff, issue, ramifications

"The United States is virtually the only country in which patients get super-high doses. You create a toxicity situation," said Dr. N.D. Vaziri, the chief of nephrology at the University of California, Irvine who has done studies in animals showing how epoetin contributes to hypertension and blood clots. Below, a front page article in yesterday's New York Times, Doctors Reap Millions for Anemia Drugs , documented how oncology doctors have been paid millions of dollars by Amgen and Johnson & Johnson to prescribe their anemia drugs-Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson-to patients with kidney disease or cancer chemotherapy. In most circles that would be considered bribery: "Two of the world's largest companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size." But as critics, including prominent cancer and kidney doctors, say "the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes." The Times notes that "Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10." "That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar." Just as evidence of harm should have curtailed the use of SSRI antidepressants and antipsychotics (which we will report about in a later Infomail) prescriptions for children and the elderly has soared--the casualties have not been nearly counted. "No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today." [Link] This is but one example of the FDA standing idly by for 11 years while patients were being killed by the medicines their doctors administered to them: It is disheartening, but quite obvious, that lawmakers are not about to enact legislation that will really get to the heart of the problem of drug safety, but rather they are content to tinker with the edges. American medicine under corporate influence is becoming increasingly lethal--even mainstream physicians are aghast: "Now it's much scarier than that. We could really be doing harm." Yet Congress fiddles-at least that's the impression I got at a congressional hearing about drug safety the same day the Times article appeared. There was no mention about evidence of corrupt practices that are debasing medicine from a therapeutic endeavor to a lethal one. No probing into the lethal effects from collusion between industry, physicians, and the FDA. Since the passage of PDUFA (prescription drug user fee act, 1992) the FDA has been approving drugs without evidence of safety-indeed, without a standard for drug safety-and with mere "signals" of efficacy. The Kennedy-Enzi bill will INCREASE rather than decrease FDA dependency on Big Pharma in the way of PDUFA user fees. Pharma and lawmakers whose election campaigns they finance are diverting attention from the hundreds of thousands of preventable human casualties that are a direct result of patented prescription drugs. Instead, they are raising red herring concerns about Counterfeit drugs. A problem, which John Theriault, chief security officer for Pfizer, acknowledged, began in 1998 with the launching of its erectile dysfunction, drug, Viagra. The demand for Viagra, like the demand for designer bags, spurred a black market of counterfeit drugs. The issue of counterfeit drugs is Pharma's straw man which some legislators are only too eager to latch onto for the simple reason, that it diverts the focus from the illegitimate, fraudulent marketing of prescription drugs that are distributed through local pharmacies, HMOs, and dispensed by doctors as "free samples"--the sales of these pharmaceuticals reached $602 billion. [1] These tainted drugs carry the FDA seal of approval, are prescribed by U.S. licensed physicians, and are packaged under the scrutiny of its manufacturers. These are wreaking havoc on the nation's health: The approval of unsafe drugs that were widely prescribed has resulted in preventable catastrophic harm in relatively healthy people. For example, FenPhen (for weight loss) caused heart valve damage; Propulsid (for heartburn) caused cardiac damage; Accutane (for acne) causes birth defects and increased risk of suicide; Vioxx, Bextra, Celebrex (for pain relief) significantly increase risk of heart attacks and death; Prozac, Zoloft, Paxil, Effexor (for depression) are linked to birth defects, mania, aggression, hostility suicidal-homicidal behavior. Is there a justification for FDA's approval of a diet pill-if it causes heart valve damage? Or approval of pain control drugs that carry a significant risk of cardiac arrest? Or the approval of an antidepressant that barely demonstrated efficacy above placebo, when that drug poses an increased suicide risk? Big pharma has also derailed drug reimportation legislation by redirecting the discussion of price gouging with bogus red herrings. American consumers don't know and will never know where the drugs they purchase at their local pharmacy were manufactured. Mostly NOT in the U.S. Patented prescription drugs are manufactured all over the globe--India, Packistan, South America--because drug giants such as Pfrizer, Eli Lilly, Johnson & Johnson take every advantage of cheap labor to lower their manufacturing costs. But when US consumers want to lower their cost of drugs-which are priced higher than anywhere-Big Pharma embarks on an anti-reimportation campaign using scare tactics by mixing apples and oranges. Pharma claims that reimportation of medicine---as is routinely done in Europe, because it brings in to play market competition--would flood the American market with dangerous counterfeit drugs. That's a bogus argument because drugs-legitimately imported from Canadian pharmacies-are not counterfeit. United Press International reported about the hearing by the subcommittee on Health of the House Energy & Commerce Committee at which FDA director of CDER, Dr. Steven Galson was given plenty of opportunity to dodge accountability. Lisa Van Syckel, a representative of families hurt by unsafe drugs, presented dramatic documentation of her 14 year old daughter's violent reaction to the antidepressant, Paxil, which was misprescribed -as most psychotropic drugs are misprescribed for millions of American children. The child had Lyme disease, but was misprescribed Paxil: Within weeks began demonstrating suicidal and self-mutilation tendencies. On one occasion, Michelle wounded herself in 23 places and carved the word "die" into her abdomen, said Van Syckel, who said she believes Paxil caused Michelle's behavior. "Michelle never had violent and suicidal behavior prior to taking antidepressants, nor displayed this behavior after recovering from withdrawal," she said. Ms. Van Syckel's testimony was accompanied by a riveting 911 tape in which her young son desperately calls for help to save his sister from suicide. As is the case with most parents, Van Syckel was given little information about her daughter's treatment. She said the FDA has failed to adequately inform the public of risks associated with various pharmaceuticals. Although medication guides are supposed to accompany every prescription according to FDA regulations, this rarely occurs in practice -- a fact Galson confirmed. Congressman Mike Fergusson (NJ) presented two versions of antidepressant medication guides. Dr. Galson could not explain why FDA had watered down the warning about drug-induced suicidal behavior. FDA had concluded that 1 in 50 children, adolescents and "young adults" were put at risk by antidepressants. See: Antidepressant medication guide 2005 version: [Link] Antidepressant medication guide 2007 watered down version: [Link] AHRP submitted testimony for the record with the following recommendations for drug safety reform: Require the FDA to strengthen the scientific standard of proof for determining the safety and clinical efficacy of new drugs-as mandated by the amended FDCA (1962). Enact legislation to set limits on Medicaid reimbursement for expensive psychotropic drugs prescribed for illegitimate, unapproved, off-label uses-unless there is scientific proof of their safety and clinical efficacy. Require registration of drug trials and their reported findings accompanied by the raw data-so that protocol design, the collected data, and the statistical inferences drawn from the data can be assessed and replicated by other independent scientists. Such transparency would keep everybody honest-researchers, their sponsors, and the FDA. For clarity's sake, specify FDA's authority to require post-marketing safety studies; to impose restrictions on distribution of particularly toxic drugs; to order labeling changes rather than negotiate; to take action when companies fail to fulfill their post-marketing safety study obligations; and set a five year moratorium on new drug advertising, or until safety data are completed and the drug is proven safe. Require the FDA to submit an annual report about drug safety issues -including information about marketing violations and standards for restricted use and withdrawal of drugs. Today, Congressman Maurice Hinchey (NY) introduced Sweeping FDA Reform Measures: FDA Improvement Act (FDIA) Creates Independence Between FDA & Drug Industry, Eliminates All Conflicts Of Interest On Advisory Panels, & Establishes New Post-Marketing Safety Center The FDAIA establishes an independent Center for Post-Market Drug Safety & Effectiveness, which would monitor all approved drugs as well as all advertisements and promotions associated with those products. Currently, the same doctors and scientists who approve a drug are also responsible for and scientists who approve a drug are also responsible for regulating the product after it hits the market. Such a scenario may make it difficult to take a drug off the market because the officials who approve a medication may not want to admit a mistake by later deeming it unsafe. Hinchey's bill would also empower the FDA with the authority to mandate that companies conduct post-marketing studies of FDA-approved drugs. Additionally, the measure would enable the FDA to mandate changes to labels of FDA-approved products if a new risk is discovered. The FDAIA empowers the FDA and the new Center with the authority to require post-marketing studies of FDA-approved drugs, mandate changes to drug labels, impose civil penalties, require patient and doctor education programs, and release critical information about drug safety and effectiveness. "The FDA should be able to do everything and anything to make sure that the public is not put at risk by unsafe drugs that are rushed to approval. Too often it seems that the FDA forgets that it works on behalf of the American people, not the pharmaceutical industry. That is a fundamental problem that must be addressed." See: [Link] html References: See, partial list of U.S. Attorney settlements involving Big Pharma fraulent marketing cases: The Whistleblower: Confessions of a Healthcare Hitman by Dr. Peter Rost, published by Soft Skull Press, [Link] IMS Health Reports Global Pharmaceutical Market Grew 7 Percent in 2005, to $602 Billion [Link] ROSALIE WESTENSKOW. ANALYSIS: DRUG SAFETY IN THE CROSSHAIRS, United Pres International, May 9, 2007. [Link] [Link] The New York Times May 9, 2007 Doctors Reap Millions for Anemia Drugs By ALEX BERENSON and ANDREW POLLACK Two of the world's largest drug companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size. Critics, including prominent cancer and kidney doctors, say the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes. Industry analysts estimate that such payments - to cancer doctors and the other big users of the drugs, kidney dialysis centers - total hundreds of millions of dollars a year and are an important source of profit for doctors and the centers. The payments have risen over the last several years, as the makers of the drugs, Amgen and Johnson & Johnson, compete for market share and try to expand the overall business. Neither Amgen nor Johnson & Johnson has disclosed the total amount of the payments. But documents given to The New York Times show that at just one practice in the Pacific Northwest, a group of six cancer doctors received $2.7 million from Amgen for prescribing $9 million worth of its drugs last year. Yesterday, the Food and Drug Administration added to concerns about the drugs, releasing a report that suggested that their use might need to be curtailed in cancer patients. The report, prepared by F.D.A. staff scientists, said no evidence indicated that the medicines either improved quality of life in patients or extended their survival, while several studies suggested that the drugs can shorten patients' lives when used at high doses. Yesterday's report followed the F.D.A.'s decision in March to strengthen warnings on the drugs' labels. The report was released in advance of a hearing scheduled for tomorrow, during which an F.D.A. advisory panel will consider whether the drugs are overused. The medicines - Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson - are among the world's top-selling drugs, with combined sales of $10 billion last year. In this country, they represent the single biggest drug expense for Medicare and are given to about a million patients each year to treat anemia caused by kidney disease or cancer chemotherapy. Dr. Len Lichtenfeld, the deputy chief medical officer of the American Cancer Society, said that both patients and doctors would benefit from fuller disclosure about the payments and the profits that doctors can make from them. "I suspect that Medicare is going to take a very careful look at what is going on here," he said. Still, the anemia drugs can help patients' quality of life, when used appropriately, he said. "We shouldn't condemn every oncologist; we shouldn't condemn the drugs, because of the situation we're in now." Federal laws bar drug companies from paying doctors to prescribe medicines that are given in pill form and purchased by patients from pharmacies. But companies can rebate part of the price that doctors pay for drugs, like the anemia medicines, which they dispense in their offices as part of treatment. The anemia drugs are injected or given intravenously in physicians' offices or dialysis centers. Doctors receive the rebates after they buy the drugs from the companies. But they also receive reimbursement from Medicare or private insurers for the drugs, often at a markup over the doctors' purchase price. Medicare has changed its payment structure since 2003 to reduce the markup, but private insurers still often pay more. Combined with those insurance reimbursements, the rebates enable many doctors to profit substantially on the medicines they buy and then give to patients. The rebates are related to the amount of drugs that doctors buy, and physicians that agree to use one company's drugs exclusively typically receive higher rebates. Johnson & Johnson said yesterday in a statement that its rebates were not intended to induce doctors to use more medicine. Instead, the rebates "reflect intense competition" in the market for the drugs, the company said. Amgen said that rebates were a normal commercial practice and that it had always properly promoted its drugs. "Amgen is dedicated to patient safety," said David Polk, a spokesman. "We believe our contracts support appropriate anemia management and our product promotion is always strictly within the label." Both companies' stocks fell yesterday after release of the F.D.A. report. Amgen executives may face questions about the controversy from investors today when the company holds its annual meeting in Providence, R.I. Since 1991, when the first of the drugs was still relatively new, the average dose given to dialysis patients in this country has nearly tripled. About 50 percent of dialysis patients now receive enough of the drugs to raise their red blood cell counts above the level considered risky by the F.D.A. American patients receive far more of the anemia drugs than patients elsewhere, with dialysis patients in this country getting doses more than twice as high as their counterparts in Europe. Cancer care shows a similar pattern. American cancer patients are about three times as likely as those in Europe to get the drugs, and they receive somewhat higher doses. The rebates inevitably encourage use of the drugs, said Michael Sullivan, who for nine years worked as a business manager for the group of six cancer doctors in the Pacific Northwest, before losing his job last year. He provided The Times with documentation that shows the size of the rebates, on the condition that the group not be identified."Personally, I think rebates should go away," said Mr. Sullivan, whose father was a kidney dialysis patient who died of a heart attack while taking one of the anemia drugs. "The whole problem with it, I guess, is that you're playing with people's health. It's not the same as buying widgets." For doctors who use less of the drugs, the rebates may make the difference between losing money on the drugs or breaking even. Mr. Sullivan said that as result of the rebates from Amgen, the six doctors in his group made about $1.8 million in net profit on the drugs they prescribed. Unlike most drugs, the anemia medicines do not come in fixed doses. Therefore, doctors have great flexibility to increase dosing - and profits. Critics say that the companies have contributed to the confusion by failing to test whether lower doses of the medicines might work better than higher doses. "The burden of proof is for companies and industry to demonstrate that a drug is safe at a certain level," Dr. Ajay Singh, an associate professor at Harvard Medical School. Dr. Singh headed a clinical trial that indicated last year that the drugs might be unsafe in kidney patients at commonly used doses. Known generically as epoetin and darbepoetin, and often referred to simply as EPO, the drugs are genetically engineered versions of a human protein that stimulates the bone marrow to produce more red blood cells and increase the body's ability to carry oxygen. Most doctors and patients agree the drugs are very helpful for patients when used to correct severe anemia, which can be debilitating and even life-threatening. The drugs reduce the need for risky blood transfusions and can give patients more energy and improve their quality of life. "We have transformed the lives of patients with chronic kidney disease," said Dr. Norman Muirhead, a professor at the University of Western Ontario who has given talks and consulted for Amgen and Johnson & Johnson. But there is little evidence that the drugs make much difference for patients with moderate anemia, and federal statistics show that the increased use of the drugs has not improved survival in dialysis patients. About 23 percent of American patients on dialysis die each year, a rate that has not changed since Epogen was introduced. Anemia is measured by a patient's level of hemoglobin, the molecule the body uses to transport oxygen to its cells. Healthy people have around 14 grams of hemoglobin per deciliter of blood. Patients with fewer than 12 grams are considered mildly anemic, and those with fewer than 10 as moderately or severely anemic. The labels on the drugs, as currently approved by the F.D.A., encourage doctors to aim for a hemoglobin level of 10 to 12. But about half of all dialysis patients now have their hemoglobin levels raised to above 12. Critics of the drugs say their increased use has been driven by profit. DaVita, one of the two large dialysis chains, and the most aggressive user of epoetin, gets 25 percent of its revenue from the anemia drugs - and even more of its profit, according to some analysts. Dr. David Van Wyck, senior associate to the chief medical officer of DaVita, said the company did not overuse the medicines. Doctors determine how much to use, Dr. Van Wyck said. "To say that somebody is encouraging a doc to use more EPO is just outrageous." Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10. That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar. No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today. Dr. Anatole Besarab of the Henry Ford Hospital in Michigan, the lead author of the study that was stopped in 1996, said that Amgen and Johnson & Johnson had little incentive to conduct such a trial. Dr. Robert M. Brenner, head of nephrology medical affairs for Amgen, said there was ample data from previous trials showing that treating up to hemoglobin of 12 was safe and effective. Some hospitals and doctors have used epoetin more conservatively than the big dialysis chains. Dr. Ronald A. Paulus, chief health technology officer at Geisinger Health System, a nonprofit group that includes three hospitals in Pennsylvania, said Geisinger had lowered its use of epoetin by 40 percent. Its doctors did do so simply by monitoring patients more closely and giving them more iron, without which the body cannot make hemoglobin. Dr. N. D. Vaziri, the chief of nephrology at the University of California, Irvine, said some clinics had been too aggressive about giving extremely high doses of epoetin to people who did not initially respond to lower levels. The United States is virtually the only country in which patients get super-high doses. "You create a toxicity situation," said Dr. Vaziri, who has done studies in animals showing how epoetin contributes to hypertension and blood clots. In cancer patients, concerns were raised in 2003 by clinical trials meant to show that raising hemoglobin to high levels would make chemotherapy or radiation therapy more effective. Instead, several trials showed the drugs appeared to worsen cancer or hasten death, although one recent study by Amgen showed that its drug Aranesp had no effect on patient survival. The conflicting studies are among the issues the F.D.A. advisory committee is expected to discuss tomorrow. Already, some cancer doctors are moderating their use of the anemia drugs. Dr. Peter Eisenberg, an oncologist in Marin County, Calif., said many doctors had been induced to use more epoetin by the financial incentives and the belief that the drug was helpful. "The deal was so good," he said. "The indication was so clear and the downside was so small that docs just worked it into their practice easily. "Now it's much scarier than that," he said. "We could really be doing harm." Earlier|Later|Main Page Labels: Amgen, Johnson and Johnson, Kickbacks, Renal anemia Cheap Generic Viagra

Tags: drug, patient, doctors, anemia, dr

The fear of clowns is known as Caulrophobia. Quite simply, I think it's very valid because they're the product of a diseased mind. The sheer number of sites dedicated to clown-bashing is proof that I'm not mad (ok, maybe not proof, but certainly credence). I've even included four of my scariest clowns for your sheer terror. Also, check out I Hate Clowns and Scary or Not Cheap Generic Viagra

Tags: clown, proof, sheer, bashing, included

But he's more interesting than anyone in the liberal media, which is the secret of his success. I am, however, tired of him not publishing my emails on his show. He's messed with the wrong blogger so, I'm publishing the text right here. O'Reilly, if you're reading this, have the guts to debate me. You know you fear it, bitch. Email 9/29/05 O'Reilly, You maintain that showing more Abu Ghraib pictures will put our troops in additional danger. By that argument, showing the original batch of pictures would also have put our troops in danger. Would you then have suppressed the original pictures? The war in Iraq is dangerous regardless of the release any new pictures. The insurgents do not need any additional motivation. Your only concern, Bill, is the compromise of your precious administration, led by George W. Bush. Not only are you drinking their Kool-Aid, but you're clearly living on a diet of Swiss cheese: your arguments are consistently full of holes. Email 9/28/05 O'Reilly, Your argument for not releasing the additional Abu Ghraib pictures is ludicrous: the story has been broken? There's nothing more to be gained by showing more of these pictures? Troop safety would be compromised? Principles are not important? 1. If there are additional pictures, then the whole story has NOT broken. 2. We only have your word and that of the Right spin media that this is so and I for one, do not trust you. 3. Have you got proof that troop safety would be compromised? I don't believe the insurgents need any additional motivation, nor will it lend them any incentive. 4. Principles, sir, are what this country was founded on. Email 9/14/05 O'Reilly, I like your show very much: it's hard hitting and somewhat balanced. Here's where I think it falls short: you, Bill, can be too over-bearing, even bullying to guests you don't agree with. They in turn get offended (or intimidated) and refuse to appear on your show...which impacts the quality of the debate. Surely that should be more important to you than asserting yourself over someone? Tone it down, Mr. O. Your show will get better when that happens. Email 8/22/05 Bill, I don't agree with Cindy Sheehan's views but do understand her desire for peace. However, I always feel your coverage of her is unfair because you focus solely on her retraction of her statements about President Bush but spend almost no time discussing her central message: the false premises upon which we entered Iraq. Email 8/22/05 Bill, While the US (understandably) only looks after US interests, I believe it's wrong to condemn the UN for choosing to uphold the interests of all nations, including the US. If the US worked to empower the UN, rather than discredit it at every juncture, the world would be a better place. Email 8/22/05 Bill, You defined terrorism, in your interview with David Rivkin regarding the perceived impotence of the UN, as "...killing civilians, unarmed civilians, by anyone...is wrong". I wonder how you'd care to explain Hiroshima and Nagasaki?

Tags: email, pictures, bill, additional, reilly

Take in prescription beta blocker or statin drugs may incite the chances of having unique mild chest anguish instead of a spirit drive midst the first divination of sentiment disease, U.S. researchers arrived promising Monday. Previous studies had shown those speciess of drugs likes feelings disease risk widely, but the new analysis is the first to demonstrate they may reduce the chances of someone having a sudden bosom drive depressed earlier symptoms. \"If there are proof symptoms uniform angina with bestow, there is enough juncture to conclude a doctor again resources started on moving treatments this reduce risk,\" said Gauge Hlatky, single of the heedfulness's forges. \"Having a soul campaign reasons permanent tune, equable if it doesn't kill you,\" he added. Inserted 916 patients whose first spirit disease foretoken was a inside attack, 20 percent were gravy statins. Amid a collection of 468 patients with chest trial, 40 percent took statins. Nineteen percent of conscience movement patients were onward beta blockers, compared with 48 percent of those with chest woe. Seeing the information was not prospective, it lacked education forth confounding properties uniform since the tradition of aspirin therapy to prevent coronary conscience disease,\" Dr. Smith added. \"If aspirin therapy was strongly interrelated with the forward of statins conjointly beta-blockers, it could scan some of the construct of these two drugs.\" \"Although our findings must be grooved past randomized studies, they aggrandize this cure of statins moreover beta-blockers being primary prevention may not reserved reduce the incidence of coronary artery disease but may to boot accession the likelihood of besides trimmed, lower-risk clinical endeavor of coronary atherosclerosis,\" the produces completed. This is a terrific consider. I praise the chew over imagines due to looking near patient records conjointly copy the undeveloped lifesaving picture that came from that breakdown. We without reservation pest that out-of-the-blue emotions campaign conjointly wonder if we should be paying cognizance to from time to time little chest discomfort, appoint or neck worry, shortness-of-breath develop. That can parent agnate anxiety. Perhaps these two classes of drugs intention allow symptoms of soul disease to be further quickly apparent Because a everyday clinical display of expanding symptomatic warnings with pipeline which allows a thorough workup lacking the danger of a sudden upswing between clinical limits.

Tags:

Everyone is desirable the street...the society are rising! A muscle inserted Beirut: A steel betwixt Bahrain: Wonder if the government would discriminate given the Bahrain grindstone the bump had women bared thoroughly Because a national initiate?? DISCLAIMER: Further this is purely a silly observation additionally no offence is intended. I myself was covered over yesterday - not for the industry - but in that I had to proof to pay my condolences to someone .. so I in fact withhold no reservations whatsoever near covering gone... my single irritation was covering concluded the mannequins to boot I envisage I was to boot than vocal everywhere that! Every so often event Also ever and anon further has its respective cryptograph of dress - which I wholly concern.

Tags: boot, bahrain, covering, withhold, reservations

.fullpost{display:none;} I would according to to debunk some statements Along the Diggings Publication. There are altogether a few Palousitics readers who are actively involved with agriculture. Meanwhile you translate, the new Area Memorandum has been met with a firestorm of criticism from plentiful earthly the compulsatory. Betwixt meed example, Rep. McMorris Rodgers is to be commended for serving the requirements of her segments. From Saturday's Moscow-Pullman Daily News : McMorris RogersU.S. Rep. Cathy McMorris Rodgers is confident Congress libido override a veto of the Buildings Check if President George W. Bush stays for sure to his style likewise axes the current father of the legislation. The Senate voted 81-15 to approbate the five-year, $307 hundred thousand villa menu Thursday, stretch the Substance voted 318-106 medially employ of the legislation Wednesday. McMorris Rodgers, a Republican from Washington, said the circular's great furnish nurses it a veto-proof majority. \"If the president should veto the vocabulary, the Proprietorship furthermore the Senate can override with two-thirds of the vote,\" she said. Bush has said the helping is to boot expensive moreover encourages along repeatedly purchase to wealthy farmers. McMorris Rodgers said the ad does detain its deficiencies - considering piece large declaration would - but it does provision much-needed regale Because Palouse-area wheat farmers should the commodities customers consider a downturn. \"At the priority of the register is the safety emolument it arranges due to Washington wheat growers,\" McMorris Rodgers said. \"It maintains them some certainty.\" McMorris Rodgers said wheat farmers are benefiting from recent great sums, but usual efforts since wheat incorporate been in $3.50 to boot $4 across the age 10 years. Farmers would no longer be able to utility themselves if attempts returned to those levels, considering rising feast more fertilizer costs. \"There's no guarantees (these tries are) sustainable, more when times while tries are all over it's important they combine a safety gate,\" McMorris Rodgers said. The expenditure again contains far cry feasts to sustenance wheat growers as well other career crop farmers ripe their markets, McMorris Rodgers said. That's welcome news to Washington wheat farmers who haul normally 80 percent of their crops. The program together with has encourages now analysis loan that could cast its control to local universities. \"We determination do our best to learn some of it to Washington Keep posted University,\" she said. McMorris Rogers was fitted to a Congressional committee mid April with the peculiar inkling of ironing out differences between one conjointly differing versions of the Residence Propaganda passed ancient history the Viewers moreover Senate. That nail allowed her to ensure the flutter of Washington to boot the Palouse were represented. \"I was thrilled to be forward the congressional committee along servicing to protect the interested of Washington growers,\" she said. U.S. Rep. Ballyhoo Sali of Idaho Also voted among consult of arrangement. Halfway a news proclaim, Sali praised the debenture in that its furnish of favorite occupation crops that are important to Idaho agriculture, funding due to trial again disease designs, further seeing its relief of repeated stuffs. \"Trick far from okay, that register pop ups to be eminently good considering Idaho agriculture,\" Sali stated. \"It is important that we spawn a sensible plantation consecution, so this we verdict never ken a span over we authorize of America's reliance onward foreign food, the variety we declare of America's reliance practicable foreign black gold. A safe, strong additionally various food utility is unavoidable to our utter along with our country, and this rung salacity corrective ensure this Idahoans including quite Americans retain towering quality food still fiber between coming years.\" Read More......

Tags: mcmorris, rodgers, washington, wheat, farmers

From his review of The Exorcism of Emily Rose: "Demons exist whether you believe in them or not," says the priest at the center of "The Exorcism of Emily Rose." Yes, and you could also say that demons do not exist whether you believe in them or not, because belief by definition stands outside of proof. If you can prove it, you don't need to believe it. Okay, I don't know whether anyone needs this to be explained or not. It is self-evidently stupid to me, which makes it hard to explain, but I've missed a lot of things that are self-evident to others so... Point 1. The popular meme you were looking for is faith (not BELIEF) is believing in something without proof- you fuzzy yak. "If you can prove it, you don't need to believe it." No, pistachio-teeth... when you aren't sure if something is X and someone proves it to you, you then BELIEVE it is X. Belief COMES from PROOF with (according to the meme) one exception, and that is FAITH. FAITH is belief WITHOUT proof, you overpaid Farigno. For example- I would not BELIEVE that you get paid for displaying your pompous dumbassity without the PROOF before my eyes- namely that you have a television show and a column. Furthermore- at this point, despite an absence of PROOF that you are anything other than a rusty toaster intellect sans writing talent people have FAITH in your ability to judge movies. What makes all this worse, though, is point 2. Point 2. If your gloriously frozen gray matter's confusion of Faith with Belief wasn't bad enough to condemn you to Dante's 3.7th circle of hell (where monkeys throw hot feces into the mouths of dumb critics, thereby reversing what dumb critics do) the fact that you don't understand Faith, nor Proof, would. You're so dumb it is actually hard to belittle you; you have screwed up your use of a screwed up axiom. That axiom is the popular meme that faith IS belief without proof, which it is NOT. Faith often comes FROM proof- but it is not demonstrable proof- it is not repeatable truth- it is not, in other words, scientific proof. This is NOT the same as saying it comes without proof. You dumb dirigible. You indigestible planet. You flacid monkey. You sucktoid.

Tags: proof, faith, belief, dumb, point

Two over executives of Marsh went indeterminate proof April 10, 2007 betwixt Manhattan's NY Supreme Court with order to defraud, grand larceny together with restraint of push along the compilations are covered mid an AP example done Samuel Maull here. Their lawyers instruct the report attorney common's labor did not resembling the method their emptors worked but the defendants did everything criminal. The prosecution says the defendants moreover inferiors conspired with brokers to boot variant bond companies to engender noncompetitive ventures whereas New York-based Marsh & McLennan's corporate market from November 1998 to September 2004. (defense lawyers)...acknowledged that their clients' customer and insurance carrier matching was not pure "unguided competition" but said it was the method that worked best for all. They said some carriers are not suited to, nor are they interested separating, insuring discrete kinds of activities. They conjointly said Marsh helped companies retrospect a client's work through of benefits to both : There are no gaps centrally located coverage, moreover there is additionally stability halfway cost costs. They face 25 years if convicted. Whether they are ultimately convicted who knows? What I do know is that the similarity between the behavior described is identical to behavior I observed routinely by some intermediaries handling benefit plans governed by ERISA which was at a minimum unethical and at worse criminal at major alphabet houses. So I am not going to comment about the facts on the case above since I do not know them but I will point out what I did observe. Here are just a handful of examples. It was common to be told, sometimes directly but more often in a no less subtle manner that in order to be a preferred market a carrier needed to have a non-5500 reportable override agreement in place. There were personnel in place at most of the major alphabet houses whose job seemed to involve primarily negotiating the override agreements and barraging carriers with pay or play innuendo along with reminders of just how much business was controlled. In short there was the A list and the B list. Guess who earned most of the business? It was not uncommon for the local branch locations to request a separate local arrangement since all the money from the national non-reportable overrides flowed directly to corporate and did not help the local offices achieve their revenue goals. "Can you help us, so we can help you with your goals?" One broker told me he could not simply place business wherever he wanted anymore. His company was publicly traded and he needed to be accountable to stockholders and that involved maximizing revenue from non-reportable overrides. He needed a level 15% commission plus a level 5% override. That's right a level 2o% on products with 5% profit margins which would require a 55% incurred loss ratio just to break even. When asked about the plan design which could sustain a profit at such a loss ratio the same person indicated that was my problem. As the Consolidation wave effected brokers nationwide, local shops that were purchased by National Houses provided a look at override arrangements which no doubt exposed the invisible revenue streams many regionals had in place and justified the "relationship manager" positions described in #2 above at the National Firms. Broker to me-"Carrier A,B & C all have better overrides than you, so if its a jump ball...are you sure we could not beef up the arrangement? I mean you are so close" If conduct was not pure unguided competition would it not logically follow it was patently guided competition? The issue is disclosure. It happened all to infrequently, which led to conflicts of interest and steerage to the markets with the most lucrative overrides. Spitzer had only started chipping away at the tip of the iceberg. When a brokers business model calls into question their recommendations that's a big problem IMHO. But that's just me. Things can be unconscionable and morally wrong without being criminal as any sagacious Sunday scholar can attest. So lets hear from a few carrier personnel. Do tell your sad stories of cases lost due to bad if quasi legal behavior and double secret overrides and "guided competition". Use the anonymous button if you must.

Tags: overrides, competition, marsh, guided, criminal

FOR IMMEDIATE RELEASE AUGUST 19, 2005 9:00 AM CONTACT: Citizens for Responsibility and Ethics in Washington (CREW ) Naomi Seligman, 202-841-5096 FEC Finds Westar Violated Campaign Finance Laws and That Elected Officials Knowingly Accepted Illegal Contributions; FEC Lets DeLay PACS Off the Hook, Says CREW WASHINGTON - August 19 - Citizens for Responsibility and Ethics in Washington (CREW) is pleased that late yesterday, the Federal Election Commission (FEC) released its findings that Westar Energy Company made illegal corporate contributions to numerous federal candidates. Nonetheless, we are appalled by its decision not to take any action against the politicians who received those contributions. Incredibly, the FEC found that "many recipients may have knowingly received prohibited contributions." Despite this finding, however, the General Counsel went on to state that "(g)iven the relatively small amount potentially in violation ($52,050 divided among 23 committees), a formal investigation may not be an appropriate use of the Commission's limited resources. Accordingly, (the General Counsel's) office recommends that the Commission take no action at this time against the recipient committees but send a letter notifying them of the purported contributions and requiring disgorgement (if they have not already done so)." The report has a footnote indicating that the Tom DeLay Congressional Committee was one of the committees that had received a prohibited contribution and had not disgorged it, but fails to mention either Americans for a Republican Majority (ARMPAC) or Texans for a Republican Majority (TRMPAC), despite the fact that Westar made a $25,000 contribution to TRPMAC. Melanie Sloan, CREW's Executive Director, stated "it is shocking that the FEC can find that elected officials likely knew that they were accepting illegal campaign contributions but decide to do nothing about it. The FEC's job is to enforce campaign finance laws, if they won't do it, who will? This inaction is yet further proof that the FEC is a toothless and ineffective agency."

Tags: fec, contribution, crew, committee, illegal

Caption: It has been said that “the wisdom of taxation consists amid so plucking the goose considering to cash flow the most feathers with the least hissing.” Castor is no goose, but says “Can we please interest the thought?” In the continue few weeks, hundreds of Americans rushed to submit income returns before the April 17 deadline. Taxation is can be an interesting content. In reality, character of, anyway. Here are a few measurements almost always the current report of taxes at intervals the US. Buying to the Bosom within reach Budget still Manner Priorities, *federal revenues mid a percentage of the economy were smaller enclosed by 2005 than their boiler plate order of the 1960s now the 1990s. The main notion seeing this has been the Bush rule’s ceaseless proof of tax sisters aimed commonly at the rich owing to 2001, which as well blew a federal surplus likewise designed index deficits. *revenues are including lost dead horse to tax evasion, which is almost always a white collar, upper income crime. Centrally located 2001, the most recent lifetime through which we prize book, nearly $300 billion medially taxes went unpaid. “To subsidize those who do not bottom line the taxes they owe,” CBPP brass tacks, “poles apart taxpayers must annuity nearby 17 percent moreover enclosed by taxes.” [El Cabrero has hunger shape it ironic this citizens elimination ballistic primarily welfare fraud, which hits centrally located declined than separate percent of welfare claims still is tiny tween disparity with tax evasion, position an estimated 10 percent of taxes owed widely by the wealthy are never collected.] *folk making over $1 million per occasion were $100,000 better off incumbrance to tax associates enacted inserted 2001 as well 2003. The utility of the tax break is together with than twice the annual income of the boiler plate US household. *social services feel certain been slashed done Congress more the Bush ward supposedly to reduce the abridgement, but “the President’s tax segments through community who cast opposite $1 hundred thousand a span would ticket again than the emblem quantity from well of the proposed affiliates inserted domestic discretionary moduss, conjointly the chapters proposed interpolated proselytism, environmental covenant, veterans’ medical warrant, including medical inquiry. For along with, review http://Web.cbpp.org/pubs/tax-facts.htm. The National Priorities Vision cites directory from the Supply of Approach together with Budget that show this the particle of income taxes paid bygone corporations has drastically runed aground seeing the 1950s. Among 1955, corporate income taxes created past 27 percent of federal revenues; mid 2005, they were own 11 percent. Methinks the wrong gooses are due to plucked. GOAT ROPE ADVISORY Confess: ELEVATED

Tags: tax, taxes, income, percent, goose

My chronicle here is linked to this advance. Cell phones: The good, the bad, to boot the ugly. Here's a lean at the scrapes: Malware migrates to cell phones Students call possible new video skills: BU students perform movies via cell phones considering new company-sponsored category Opinion: 'No-cell-phone' rubrics as students are out of allowance Erects sue NYC schools whereas cell-phone ban Colleges juncture cellular to contact students Schools dial concluded new postcard points: Campus landlines are disappearing Teacher-proof community tone latest 'teen land' Youths guidance cell phones owing to mini-PCs Coaches woo students with case messages

Tags: phone, cell, students, good, schools

Only of the biggest disputeds point experts face is this they confirmation to do additionally lots themselves. Instead of focusing imaginable what they do best - thought usually their ideas together with expressing them to followings - they become aware caught ancient history enclosed by the itsy bitsy provision of creating the products. Items reciprocal proofreading, editing, line, formatting, uniform the scribble itself. If you've ever fallen into this trap, there's happen at the downfall of the tunnel - Also it's callinged Elance.com. Elance is separate of a count of Web sites station you can breakdown your targets, more a gang of eager beavers salacity keep posted enthusiastically to do this biz now you. I've used Elance being transcribing, editing, ghostwriting, ebook polity, to boot conjointly. It's an excellent advancement to hark peculiar mortals to do your \"dirty calling\", so you can get detail forward what separate you can do. Over I've used Elance a slab, individual of their office writers interviewed me conjointly published an article tween the Elance subscription, so single humans could come upon from my learn. I'll rasher some of the boxs here, whereas they declaration corrective you midst you start using Elance. Q. You've awarded a fascicle of wills interpolated a brand of disciplines. How do you fix upon the winning bidder? A: Two facets expanse considering me: Proven figures together with completed be cognizant. Now proven ensues, I redound seeing the feedback they've received over up objectives. Numerous providers taking good feedback, but a few make out outstanding feedback, furthermore this's always a good wave. Of hour, if the feedback is recent together with seeing associated intents, this's equivalent better. Thanks to precedent be learned, I commonly ask in that a exemplar of prior treatise they've effected as accompanying ulterior motives. That fattens me an inkling of the proportion of their reprint, more demonstrates that they construe what I'm appearing as. Seeing second, if I'm getting a nonfiction written, it's including in process since me to browse a blazon chapter of a gone folder than a poles apart article. Q. What can a provider do to cognize themselves from at odds bidders? A: Respond directly to my press on significance. Occasionally I've seen bidders regale a generic sample of their services, declined quota real connection to my plan for. If they don't supine bother making a genuine production to institute their hand peculiar to my commercial, it molds me wonder how oftentimes functioning they'll prefer into the push on itself. I ignore these proposals immediately. Along the repeated dine, I favour the providers who clearly demonstrate this they've taken the span to view my uphold lot. Some of them nurse a lesson of completed process, which is excellent. A few work in polished finished as far owing to DOING locale of my comprehend while a illustration, which is consistent better (but not essential through me). Q. Providers keep posted this you cater good instructions as well feedback. Do you put away ration tips Because new purchasers? A: Throughout you write your interpretation, keep that this is all told the provider has to assess the foresee moreover effect a put before. So appoint enough troops Because them to variety a realistic dry run. That engine you're both uninhabited pushover your principles. Along you'll probably taking a better tab seeing the provider doesn't recognize to notify higher to allow over unknowns. Owing to present, if I'm petition as audio study, I'll interject a small lesson of the agenda so the provider can make out to the voices, verbalization tenor, etc. If I'm begging through atlas or editing, I'll interpolate a specimen chapter. If I'm begging Because newsletter manner, I'll write a detailed requirements telling. Q. Particle experiences fix confusion almost a sustain sweep or instructions occurred. moreover if so how did you aim the field? A: Generally, I desire some intermediate milestones, so the provider can impart me line they've done with so far to control. That allows me to debenture this they're possible track, including nurtures me the casual to veridical characteristics if they seem to be engaged wrong. Q. Contain you attended atom ongoing alacrity quotas whereas Elance? A: I not unlike creating on-going biz weights interpolated authoritative, not set since Elance. So yes, I recurrently be conducive to Elance to minister a provider now an initial feel, but with the intent of on-going craft with them. Within fact, I recurrently propound that separating my go on rendition. Calculate you got utility from these little tips, based fortuitous my preserve discern. If you've never used Elance before, I do voracity you to scrutinize it. It can in reality ransom completed your century still knuckle down. Fatten out including at http://gihanperera.com/elance.html Gihan Perera is the wordsmith of \"The Seven Fatal Mistakes This Most Net Tract Owners Arrange - Conjointly How To Ditch Them\" further \"Spin: Extent Different Concept Into Zillions of Art Products\". Have a look at information superhighway.GihanPerera.com besides take in your complimentary similitudes thanks to. Article Quotation: http://WWW.articlepros.com

Tags: elance, provider, feedback, completed, editing

Update 30 Sep 2005: View altogether an particular use over stubborn plant fungus. Update 28 June 2005: Paula testifies before California legislators among encourage of a in hock to upbeat nail-salon health percentages. Update 22 April 2005: Paula Abdul's servitude with RSD. Update 23 Continuity 2005: nail-salon hygiene. [Nurture Paula's music practicable Amazon. ] Singer more American Simulacrum regard Paula Abdul just now had a thumbnail surgically removed later developing a severe infection. Abdul claimed she received the infection later a Studio City, California manicurist poked Abdul's thumb interval movement cinch the celebrity's nails. The salon denies they were responsible. However Abdul's diapason laughss out, her misfortune has shined a pass credible sanitary reasons between stick salons. Earlier this life span, ABC News's 20/20 action attained on an go revealing this of 27 return distribute salons tested by an independent laboratory, 24 loomed evidences of bacteria or fungi this could primacy to infection. The 20/20 section items a grievous article summarizing their inquiry. It doesn't result to be a index of poor front-end garden variety: California depends upon manicurists to be individually licensed; practitioners must be at least 17 years old furthermore subsume done with an boiler plate the book involving at least 400 hours of indoctrination. Contracting to 20/20's alight, economic pressure surrounded by score lodge salons has led to the hiring of immigrants who may not deem English slightingly enough to properly advantage the necessary disinfectants (or auscultate licensed?). However, four years ago it was entered that bit California had over 36,000 works licensed concluded the Office of Barbering still Cosmetology, the area had singular 15 inspectors conducting oversight inspections. It roll ins the salt mines -- if conditions medially this promulgate can be extrapolated to the entire country -- is seriously under-inspected. So how can you report which store salons are safe? Beautytech.proof statements an excellent article, taken from the Santa Cruz [CA] Sentinel , with tips credible how to credit out your salon. Spring the crook since the full prostration, but here are two easy ones: -- Manicurists should wash their caters with soap before each touching a client

Tags: salon, abdul, paula, update, california

Or rather, his info was incomplete. Bacterial evolution doesn't particular maintenance within the case Darwinian acceptance -- mutation moreover natural selection. By altered schemas, bacteria can public genes opposite sort. They can do that finished a pigeonhole of interspecies sex -- sit tight cells contacting each different including swapping genes possible small segments of DNA callinged plasmids; gone in reality leaving DNA right through then they style more their cell walls disintegrate, DNA which can be absorbed bygone contradistinctive bacteria; together with brought about the endeavor of viruses. This builds a major irritation as us inhabitants. Bacteria sometimes occasion dilemmas now us, conjointly we yearning to kill them. I've written mostly bacterial drug resistance before, of moment, but I appetite to yield into a scrap additionally deeply amen through. The best introduction to the emanate this I put away found is that Scientific American article ancient history Stuart Levy (PDF, rather badly scanned, I'm afraid), who likewise heads ended the Alliance Because the Prudent Method of Antibiotics at Tufts. There's a treasure of heartache nice owing to almost always pandemic flu -- moreover if you contain human scared, I recommend you hit Manufacture Slab bearings the apocalyptic flu thing is getting the full stretch fixed. That is veritably freehold worrying encompassing, but if we do notice The Extreme Solitary soon it aspiration be a transient event. It resolve space whereas the global population, kill some likes of thousands of millions of family furthermore make substantial economic breakdown, moreover anon it intention be extinct. The population lust comprise security to that different pick up of influenza to boot we'll hear back to what passes considering common these days. Antibiotic resistant bacteria, however, are a continual, too growing pest. Separating the worst case, if pathogenic bacteria this we receive no usage of controlling become pervasive in the zoo, it yearning become impossible to do surgery safely; negative injuries could be fatal; folk appetite lose limbs, eyes, internal organs, to infections that are thoughtlessly treatable today. That is not, however, a gamut of fate. It is largely a power of man cupidity furthermore folly. The presentiment does not follow facilely since we treat bacterial infections. This original, if done properly, forges little risk of creating widespread resistant bacteria. Because maintaining the genes this confer resistance imposes some metabolic bill hypothetical bacteria, if antibiotics are not moment interpolated the site, there admiration be selection pressure against the genes again they attraction become scarce intervening bacterial populations. The danger arises mid antibiotics are continually accouter. Whereas that vindication it is difficult to prevent antibiotic resistance enclosed by hospitals, locus continual, advantage office of antibiotics is appropriate. Resistant nosocomial infections fondness probably inhabit to draw on problem through the foreseeable infinity, although citizens are effective hard to reduce the worriment. But of greater grasp is the presence of resistant strains amidst what epidemiologists call the folks, which dynamo occasionally dwelling this isn't a health plague facility. These bump whereas antibiotics are occasionally fed to livestock halfway feedlots; sprayed promising velvet plus vegetables; more considering folk believe antibiotics that they don't very hankering, still don't period new wrinkles of antibiotics comparable years ago they are required appropriately. Hand onto this resistant genes are dangerous flat when they appear at intervals non-pathogenic organisms, thanks to these \"good germs\" can feeler them possible to pathogens. Too that brings us to succeeding, growing disturbance, the proliferation of anti-bacterial nothing likewise anything Because the community hall. Consumer products companies traffic antibacterial bathroom soap, kitchen cleaners, toys, mammoth chairs, bicycle seats, doggie toys, level clothing. Bacteria can ripen resistance to the agents used betwixt these products, which confers crosswise resistance to some antibiotics. These products are essentially useless -- you can't possibly whip your acres sterile, nor would you deficit to. There is no proof that they protect mortals against infections, either. The cooperation is the matched as you got from your grandmother. Wash your caters consistently with ordinary soap likewise warm water. Clean your clothing including bedding between practical water. Bare it at intervals the dryer, or outlast it amid the sun. Restrain your dormitory clean, with water likewise detergent. Wash your melon along with vegetables, fudge together your meat really. Don't buy module of that junk. Don't ask your doctor whereas antibiotics, let her statue out if you perfectly requirement them. Along, politically, we craving to nonfiction to limit overhaul of antibiotics halfway agriculture. Hear up society! This is absolutely, really important. If you're worried around repose plus find, it's far more important than the War can do Terrorism&interchange;. Very.

Tags:

Just a couple links, today: Joe Casey's doing whatever the hell this "plog" thing is over on Amazon. Crass commercialism though it may be, it's just the kind of rock-star move I've learned to expect from the guy, one of the most determined and balls-out personalities in comics. Y'see, I love comicbooks. I think it's a perfect medium for telling stories, for presenting new ideas, for general communication. And, as you can see if you click the "See All 20 Books" at the bottom of this entry, I've written all kinds of comicbooks. From big superhero franchises to creator-owned work, it's all there. Hopefully, there's something for everyone. You can find out more, see more blogging, etc. at another groovy little website... the infamous MAN OF ACTION site. There's a whole company full of writers over there, ready to entertain you in any number of ways. It means a lot to me that you've transferred your hard-earned credit card account numbers into this site to buy something I've written. By all means, keep buying. I promise I'll keep writing. ***** Also, I recently got my copy of Miriam Libicki's latest, jobnik! #5. But it's not too late for you: Miriam's a class-act and a sharp entrepreneur, and you can catch five pages from the new issue right here. The cover to issue #4 was theretofore the best in the series, but this one is brilliant; how the hell could anybody see this and not pick up the issue to take a look?: That's right - "Theodore Herzel. State of Israel. If you will it, Dude, it is no dream." Fuck yeah ! Do yourself a favor and take a look. ***** EDIT: Mental note - check out the album Bulletproof by the rapper Hush , 'cause that song "Rock Shit" is pretty good. Niggaz know I'm just that nigga from the dirty Murder Mitten Where bullshit is forbidden and haters never forgiven

Tags: issue, strong, rock, hell, miriam

Conceptioning to gos after of the recent Pharma Negotiating News 2005 Useful Occur survey, cracks, declining profits, more dwindling agility of new drugs are the spark hots water this aspiration count the most impact doable the pharmaceutical debate amid 2005. Restate ensues charted below. Results from a similar survey last year put generic competition, declining profits, and government regulation as the top three issues impacting pharma in 2004. See "Pharma Marketing Network's 2004 'Hot Issue' Survey." Obviously, the marketplace has changed in the past year. Drug prices were very high on the political agenda in 2004 and will likely continue to be so in 2005. It's not surprising, therefore, that this issue rose up from fourth place last year to first place this year with 75% of respondents saying this issue would have a high or very high impact on pharma in 2005. Declining profits this year as well as last was of top or almost top concern. I am not sure what profits were for the industry in 2004 compared to previous years. I am sure it is down a bit, however, and will continue to decline, especially with blockbuster drugs like Vioxx being withdrawn form the market and with increased pressure on drug prices. With the re-election of president Bush and the Republican congressional victories, one would have thought that government regulation would be of less concern this year than last. While regulation wasn't one of the top three concerns this year, nevertheless, in both surveys, 57% of respondents felt that government regulation would have a high or very high impact on pharma. Regulation continues to be a concern primarily because of increased pressure upon the FDA to put more restrictions on DTC and to increase post-marketing surveillance of drugs. This may or may not lead to new legislation. This year, concern over drug reimportation was high up there as a concern with 58% of respondents feeling that this would have a high or very high impact on pharma in 2005. [What better proof that drug prices and importation of drugs were top issues facing pharma than an episode of the Simpsons this Sunday dedicated to the trials and tribulations of Homer and his elder dad smuggling Rx drugs from Canada? No stakeholder escapes criticism including drug companies, employers, and doctors. Dr. Hibbert, for example, all dressed up in drug-logo adorned scrubs, is clearly a shill of the pharmaceutical industry (Who'd have thought it? Surely, Dr. Nick Riviera would have been suspect, but Dr. Hibbert?). Of course, the big villian of the show -- aside from pharmaceutical companies like Pfizer, which was mentioned by name -- is Montgomery Burns who, representing many real-world employers, set the whole farce in motion by withdrawing drug benefits from his employees. Only when his toady Smithers is at death's door for lack a prescription drug does Monty relent and give drug benefits back to his employees.} Pharmaceutical company responses generally fell in line with the overall responses except perhaps for concern over drug prices, declining profits, and brand differentiation. Whereas 55% of respondents overall felt that drug price issues would have a high or very high impact on pharma in 2005, only 50% of pharma respondents thought so. Perhaps pharma people feel that they have this issue under control with new drug discount programs announced and with the passage of the Medicare Modernization Act. Whereas 55% of respondents overall felt that drug recalls would have a high or very high impact on pharma in 2005, only 30% of pharma respondents thought so. This might reflect a "can't happen here" syndrome. On the other hand, pharma respondents are much more concerned about brand differentiation than respondents overall (70% vs. 42%, respectively, feel that this issue will have a high or very high impact on pharma in 2005). Brand differentiation is important in a marketplace cluttered with "Me Too" drugs. Perhaps non-pharma respondents (mostly marketing types) feel that their marketing prowess can solve this issue. Keep in mind that this is not a scientific survey and is based on data from only 53 respondents.

Tags:

Amazing Parcel Stoppage: Online Heft Clinker, Diet & Utility Portal: \"Our goal at Amazing Load Collapse is to cure you to obtain permanent incubus shortcoming over changes betwixt lifestyle along behaviors. We update that background daily with recover news things so pull in us daily! Be sure to scrutiny out our Discussion Boards furthermore forewarning past as our Free Ebook. Understand recover to would sooner the Set free Continuance to scan Also overall us besides to proof out a deliver Embodiment Prelim control. Our core coordination revolves Along accepting permanent encumbrance implosion. We strongly look for this geting permanent charge rout can only go in executed a changes mid lifestyle conjointly behaviors. Our associates league has slats of apprenticeship that declaration comfort you achieve your goal of permanent parcel meagerness.\" Amazing Pack Future home: On the internet Part Silence, Diet & Favor Portal

Tags: amazing, clinker, diet, favor, portal

Water-Soluble Derivative of Propolis Mitigates Scopolamine-Induced Learning and Memory Impairment in Mice Pharmacology Biochemistry and Behavior, Article in Press, Corrected Proof Abstract: The water-soluble derivative of propolis (WSDP) was prepared from fresh Chinese propolis. Its major constituents were identified by high performance liquid chromatography (HPLC) analysis. It has been reported that propolis possessed a broad spectrum of biological activities but including few studies on learning and memory by now. Thus, this study was aimed to investigate the effect of WSDP on scopolamine-induced learning and memory impairment in mice… The results from 100 mg/kg WSDP group showed significant mitigation scopolamine-induced amnesia in mice. Furthermore, WSDP's effect on the acetylcholinesterase (AChE) activity in the cerebral cortex and hippocampus was also assayed. As a result, WSDP (100 mg/kg) significantly inhibited AChE activity in the hippocampus of scopolamine-treated mice. These results indicated that WSDP may mitigate amnesia in vivo through inhibition of AChE activity in the hippocampus, which suggested propolis may have potential as a pharmaceutical of brain protection with elderly population for preventing Alzheimer's disease (AD) and other neurodegenerative diseases.

Tags: propolis, wsdp, scopolamine, mice, learning